Genetic variants of the lipoprotein lipase gene and myocardial infarction in the Central Valley of Costa Rica

Journal of Lipid Research

Volumn 45, Issue 11, 2004, Pages 2106-2109

  Yang, Yadong ^a   Ruiz Narvaez, Edward ^a   Niu, Tianhua ^b   Xu, Xiping ^a   Campos, Hannia ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Cardiovascular disease; Epidemiology; Hispanic; Risk factor; Single nucleotide polymorphism

Indexed keywords

DNA FRAGMENT; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; COSTA RICA; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LPL GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; METABOLISM; MIDDLE AGED; RISK; STATISTICAL MODEL;

ADULT; AGED; ALLELES; COSTA RICA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HETEROZYGOTE; HUMANS; LIPOPROTEIN LIPASE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; VARIATION (GENETICS);

EID: 21644435380     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400202-JLR200     Document Type: Article

References (28)

1. Mead, J. R., S. A. Irvine, and D. P. Ramji. 2002. Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 80: 753-769.
2. Merkel, M., J. Heeren, W. Dudeck, F. Rinninger, H. Radner, J. L. Breslow, I. J. Goldberg, R. Zechner, and H. Greten. 2002. Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL it also increases triglyceride hydrolysis and whole particle lipoprotein uptake. J. Biol. Chem. 277: 7405-7411.
3. Takahashi, S., J. Suzuki, M. Kohno, K. Oida, T. Tamai, S. Miyabo, T. Yamamoto, and T. Nakai. 1995. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J. Biol. Chem. 270: 15747-15754.
4. van Bennekum, A. M., Y. Kako, P. H. Weinstock, E. H. Harrison, R. J. Deckelbaum, I. J. Goldberg, and W. S. Blaner. 1999. Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester. J. Lipid Res. 40: 565-574.
5. Murthy, V., P. Julien, and C. Gagne. 1996. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol. Ther. 70: 101-135.
6. Hokanson, J. E. 1997. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int. J. Clin. Lab. Res. 27: 24-34.
7. Zhang, H., H. Henderson, S. E. Gagne, S. M. Clee, L. Miao, G. Liu, and M. R. Hayden. 1996. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim. Biophys. Acta. 1302: 159-166.
8. Minnich, A., A. Kessling, M. Roy, C. Giry, G. DeLangavant, J. Lavigne, S. Lussier-Cacan, and J. Davignon. 1995. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J. Lipid Res. 36:117-124.
9. Wittrup, H. H., A. Tybjaerg-Hansen, and B. G. Nordestgaard. 1999. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation. 99: 2901-2907.
10. Ehrenborg, E., S. M. Clee, S. N. Pimstone, P. W. Reymer, P. Benlian, C. F. Hoogendijk, H. J. Davis, N. Bissada, L. Miao, S. E. Gagne, L. J. Greenberg, R. Henry, H. Henderson, J. M. Ordovas, E. J. Schaefer, J. J. Kastelein, M. J. Kotze, and M. R. Hayden. 1997. Ethnic variation and in vivo effects of the -93t→g promoter variant in the lipoprotein lipase gene. Arterioscler. Thromb. Vasc. Biol. 17: 2672-2678.
11. van Bockxmeer, F. M., Q. Liu, C. Mamotte, V. Burke, and R. Taylor. 2001. Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids. Atherosclerosis. 157: 123-129.
12. Wittrup, H. H., A. Tybjaerg-Hansen, S. Abildgaard, R. Steffensen, P. Schnohr, and B. G. Nordestgaard. 1997. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J. Clin. Invest. 99: 1606-1613.
13. Clee, S. M., O. Loubser, J. Collins, J. J. Kastelein, and M. R. Hayden. 2001. The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease. Clin. Genet. 60: 293-300.
14. Chen, W., S. R. Srinivasan, A. Elkasabany, D. L. Ellsworth, E. Boerwinkle, and G. S. Berenson. 2001. Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa Heart Study. Atherosclerosis. 159: 367-373.
15. Humphries, S. E., V. Nicaud, J. Margalef, L. Tiret, and P. J. Talmud. 1998. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler. Thromb. Vasc. Biol. 18: 526-534.
16. Gagne, S. E., M. G. Larson, S. N. Pimstone, E. J. Schaefer, J. J. Kastelein, P. W. Wilson, J. M. Ordovas, and M. R. Hayden. 1999. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin. Genet. 55: 450-454.
17. Tunstall-Pedoe, H., K. Kuulasmaa, P. Amouyel, D. Arveiler, A. M. Rajakangas, and A. Pajak. 1994. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 90: 583-612.
18. Schneider, S., D. Roessli, and L. Excoffier. 2000. Arlequin Version 2.000: A Software for Population Genetics Data Analysis. Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva, Geneva, Switzerland.
19. O'Brien, K. D., D. Gordon, S. Deeb, M. Ferguson, and A. Chait. 1992. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J. Clin. Invest. 89: 1544-1550.
20. Olivecrona, G., and T. Olivecrona. 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6: 291-305.
21. Mailly, F., Y. Tugrul, P. W. Reymer, T. Bruin, M. Seed, B. F. Groenemeyer, A. Asplund-Carlson, D. Vallance, A. F. Winder, G. J. Miller, J. J. P. Kastelein, A. Hamsten, G. Olivecrona, S. E. Humphries, and P. J. Talmud. 1995. A common variant in the gene for lipoprotein lipase (Asp9Æsn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 15: 468-478.
22. Zhang, Q., J. Cavanna, B. R. Winkelman, B. Shine, W. Gross, W. Marz, and D. J. Galton. 1995. Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease. Clin. Genet. 48: 293-298.
23. Mailly, F., R. M. Fisher, V. Nicaud, L. A. Luong, A. E. Evans, P. Marques-Vidal, G. Luc, D. Arveiler, J. M. Bard, O. Poirier, P. J. Talmud, and S. E. Humphries. 1996. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM Study. Atherosclerosis. 122: 21-28.
24. Reymer, P. W., E. Gagne, B. E. Groenemeyer, H. Zhang, I. Forsyth, H. Jansen, J. C. Seidell, D. Kromhout, K. E. Lie, J. Kastelein, and M. R. Hayden. 1995. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat. Genet. 10: 28-34.
25. Fisher, R. M., F. Mailly, R. E. Peacock, A. Hamsten, M. Seed, J. S. Yudkin, U. Beisiegel, G. Feussner, G. Miller, S. E. Humphries, and P. Talmud. 1995. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J. Lipid Res. 36: 2104-2112.
26. Jemaa, R., F. Fumeron, O. Poirier, L. Lecerf, A. Evans, D. Arveiler, G. Luc, J. P. Cambou, J. M. Bard, J. C. Fruchart, M. Apfelbaom, F. Cambien, and L. Tiret. 1995. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Temoin sur l'Infarctus du Myocarde. J. Lipid Res. 36: 2141-2146.
27. Hokanson, J. E., and M. A. Austin. 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3: 213-219.
28. Sacks, F. M. 2002. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am. J. Cardiol. 90: 139-143.